X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
D | 2024-02-28 | BIOBI | Ernst Timothy S | EVP, GC, Sec | S - Sale+OE | $330.55 | -2,500 | 3,397 | -42% | -$826,375 | |||||
D | 2024-02-27 | BIOBI | Crowley Michael | EVP, GBL Commercial Operations | S - Sale+OE | $336.00 | -3,000 | 6,942 | -30% | -$1,008,000 | |||||
2023-12-12 | BIOBI | Wright Dara | EVP, Pres, CDG | S - Sale | $299.16 | -1,200 | 1,499 | -44% | -$358,992 | ||||||
2023-11-28 | BIOBI | Crowley Michael | EVP, GBL Commercial Operations | S - Sale | $305.10 | -642 | 6,942 | -8% | -$195,874 | ||||||
D | 2023-08-30 | BIOBI | Ernst Timothy S | EVP, GC, Sec | S - Sale+OE | $395.60 | -2,350 | 2,416 | -49% | -$929,667 | |||||
2023-08-23 | BIOBI | Ernst Timothy S | EVP, GC, Sec | S - Sale | $384.69 | -300 | 2,416 | -11% | -$115,407 | ||||||
2023-06-15 | BIOBI | Crowley Michael | EVP, GBL Commercial Operations | S - Sale | $379.39 | -500 | 6,040 | -8% | -$189,695 | ||||||
2023-06-06 | BIOBI | Ramalingam Ajit | SVP, Chief Accounting Officer | S - Sale | $368.30 | -198 | 0 | -100% | -$73,053 | ||||||
D | 2023-03-08 | BIOBI | Ernst Timothy S | EVP, GC, Sec | S - Sale+OE | $486.43 | -1,746 | 2,671 | -40% | -$849,300 | |||||
2022-11-10 | BIOBI | Ramalingam Ajit | SVP, Chief Accounting Officer | S - Sale | $421.87 | -379 | 0 | -100% | -$160,051 | ||||||
2022-08-05 | BIOBI | Ramalingam Ajit | SVP, Chief Accounting Officer | S - Sale | $537.00 | -518 | 98 | -84% | -$278,166 |
A | Amended filing |
D | Derivative transaction in filing (usually option exercise) |
E | Error detected in filing |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |